主管:中国科学院
主办:中国优选法统筹法与经济数学研究会
   中国科学院科技战略咨询研究院

中国管理科学 ›› 2024, Vol. 32 ›› Issue (11): 168-179.doi: 10.16381/j.cnki.issn1003-207x.2021.2214

• • 上一篇    

数据驱动的疫情检测和医疗资源动态分配的联合决策方法

都牧()   

  1. 大连理工大学经济管理学院,辽宁 大连 116024
  • 收稿日期:2021-10-28 修回日期:2022-03-10 出版日期:2024-11-25 发布日期:2024-12-09
  • 通讯作者: 都牧
  • 基金资助:
    国家自然科学基金项目(71531002); 中央高校基本科研业务费项目(DUT23YG119)

A Data-driven Decision-making Approach for Joint Mass Screening and Pharmaceutical Resource Allocation in Epidemic Outbreak

Mu DU()   

  1. School of Economics and Management,Dalian University of Technology,Dalian 116024,China
  • Received:2021-10-28 Revised:2022-03-10 Online:2024-11-25 Published:2024-12-09
  • Contact: Mu DU

摘要:

在突发性大规模疫情初期,传染病的传播参数和疫情状态通常是未知的,分区域、有针对性地对人群进行主动检测,对于预测疫情传播趋势、制定科学精准的疫情应急资源分配决策具有重要作用。结合新冠肺炎疫情应急管理实践,提出了疫情检测和医疗资源分配联合决策这一新的应急管理问题。通过实施主动性的疫情检测,增加疫情状态观察数据来源,并结合确诊数据周期性到达的特点,提出一种融合随机规划和滚动优化的数据驱动的在线决策方法,通过不断学习新到达的数据逐步缩小不确定参数空间,并利用抽样将其表示为经验概率,从而将疫情检测和医疗资源分配决策问题刻画为随机动态规划问题,并采用滚动优化方法求解,实现在线决策。经环境交互模拟器验证,提出的数据驱动决策方法在人道主义和经济效率方面均优于现有常用决策方法。

关键词: 疫情应急管理, 数据驱动决策方法, 疫情检测, 医疗资源分配

Abstract:

Conducting targeted mass screening and allocating limited pharmaceutical resources accurately and timely to in different regions is of great importance for epidemic control, especially in a sudden large-scale epidemic outbreak involving asymptomatic patients. Based on the practice of emergency management in COVID-19, a new problem, namely, joint multi-period mass screening and pharmaceutical resource allocation in the epidemic outbreak, is proposed. It is a sensing and control problem of spatial-temporal dynamic network with uncertain transmission parameters, non-stationary transmission dynamics, and partially observable system state. To solve this problem, a data-driven optimization approach using the data of periodically diagnosed cases for the decision-making process is proposed, which combines stochastic programming and rolling-horizon optimization methods. By learning the new arrival data, the uncertain parameter space is continuously reduced and can be expressed as an empirical probability. Then, the epidemic detection and pharmaceutical resource allocation problems are formulated as stochastic dynamic programming problems, which are solved by the rolling horizon optimization method. Finally, an environment interaction simulator is established to verify the superiority of the proposed data-driven decision-making approach over the existing practical decision-making method, and the effectiveness of resource allocation strategies under different resource-level constraints as well as decision-making preferences are discussed. The main findings of our study that can offer policy insights for public sectors include the following four folds. First, implementing large-scale mass screening at the early stage of the epidemic outbreak plays a great role in improving the efficiency of epidemic control and reducing the total number of infections. Second, given an intervention budget, increasing the mass screening scale has a larger marginal effect on improving the efficiency of epidemic control than increasing the amount of pharmaceutical resources. Third, when the intervention resources are sufficient, a more exclusive decision-making preference can help reduce the total infection, while a more inclusive decision-making preference can improve the economic efficiency of resource utilization. Fourth, when intervention resources are in shortage, making decisions moderately with a slightly tilting to some severely infected areas can achieve a good performance in both humanitarian and economic efficiency. An online decision-making framework and optimization approach are provided for resource allocation of public health management departments in epidemic outbreaks. By introducing the corresponding mechanism model and data, the proposed approach can provide epidemic mass screening and pharmaceutical resource allocation decision support for other large-scale epidemic outbreaks (such as H1N1, and Ebola).

Key words: emergency management in the epidemic, data-driven decision making, mass screening in the epidemic, pharmaceutical resource allocation

中图分类号: